1. Academic Validation
  2. Human carboxylesterases: a comprehensive review

Human carboxylesterases: a comprehensive review

  • Acta Pharm Sin B. 2018 Sep;8(5):699-712. doi: 10.1016/j.apsb.2018.05.005.
Dandan Wang 1 Liwei Zou 1 Qiang Jin 1 Jie Hou 2 Guangbo Ge 1 Ling Yang 1
Affiliations

Affiliations

  • 1 Institute of Interdisciplinary Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • 2 Dalian Medical University, Dalian 116044, China.
Abstract

Mammalian carboxylesterases (CEs) are key Enzymes from the serine hydrolase superfamily. In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade. These two Enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants. The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs. This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators. The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism. It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.

Keywords

CES1; CES2; Human carboxylesterases; Inducer; Inhibitor spectra; Substrate preference.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》